Revolutionary Blood Test Offers Real-Time Insights Into Metabolic Health Trends
In a significant new development, patients can now monitor their metabolic health with just a simple finger prick, yielding immediate results through two measurements. This innovative approach, as reported by the American Nutrition Association (ANA), underscores an urgent need for health system reforms to ensure that individuals can effectively act on their results, depending largely on their local regulations and the health insurance they have.
ANA's CEO Corinne Bush and Senior Director of Nutrition Programs Amy Smith highlight the disparity in access to nutrition-focused healthcare. In their recently published piece in Frontiers Policy Labs titled "From Biomarker to Practice Policy Pathways for the Glucose Ketone Index in Personalized Nutrition," they argue that the healthcare system is lagging behind advancements in personalized nutrition and metabolic science. The glucose ketone index (GKI), a finger-prick biomarker, could potentially assist in managing various metabolic disorders such as cancer, cardiovascular diseases, type 2 diabetes, obesity, and neurodegenerative conditions, all of which are projected to contribute to an increasing burden of global diseases in the coming decades.
However, a pressing issue remains: while patients can promptly measure their metabolic health, they often lack access to qualified professionals who can help interpret these results. Bush and Smith note that most medical schools in the U.S. do not prioritize clinical nutrition training, with fewer than 15% of healthcare providers feeling confident enough to discuss nutrition critically with patients. Meanwhile, Certified Nutrition Specialists (CNS), who are trained specifically to interpret such metabolic data, are underutilized in healthcare settings. As stated by Bush and Smith, "When patients can measure their own metabolic state in real time but can't access a qualified professional to help interpret it, the system has failed at a basic level. Fixing that failure is a policy choice, and the mechanisms to make it are already available."
To bridge this gap, the Outlook makes three crucial recommendations: 1. Clinical societies should publish clear guidelines on using tools like the GKI. 2. States need to update licensing laws for nutrition professionals, enabling them to practice medical nutrition therapy based on demonstrated competencies rather than outdated regulations. 3. Insurance companies should reimburse biomarker-informed nutritional care rather than treating it as an optional service.
Bush and Smith emphasize that reimbursement reform could have the most immediate impact. With healthcare payers having a financial incentive to mitigate chronic disease costs, they argue that covering biomarker testing in accordance with established guidelines can be an immediate change that insurers could implement.
The Policy Outlook represents ANA's most notable engagement with policy discourse beyond professional education. This marks a pivotal moment for the organization as it advocates for a credentialed workforce in personalized nutrition parallel to emerging clinical science on a global scale.
To access the Policy Outlook, visit policylabs.frontiersin.org, where it sits alongside a lead article on GKI, a reader-friendly piece for younger audiences through Frontiers for Young Minds, and an expert viewpoint by Dr. Evelyne Bischof of the Healthy Longevity Medicine Society. A deep-dive webinar will follow on September 16, 2026.
About the American Nutrition Association: The ANA is a nonprofit organization dedicated to embedding personalized nutrition within the healthcare framework. They oversee the Certified Nutrition Specialist® (CNS®) credential, an NCCA-accredited certification, and engage in nationwide advocacy, continuing education, and workforce development for nutrition professionals.
ANA's CEO Corinne Bush and Senior Director of Nutrition Programs Amy Smith highlight the disparity in access to nutrition-focused healthcare. In their recently published piece in Frontiers Policy Labs titled "From Biomarker to Practice Policy Pathways for the Glucose Ketone Index in Personalized Nutrition," they argue that the healthcare system is lagging behind advancements in personalized nutrition and metabolic science. The glucose ketone index (GKI), a finger-prick biomarker, could potentially assist in managing various metabolic disorders such as cancer, cardiovascular diseases, type 2 diabetes, obesity, and neurodegenerative conditions, all of which are projected to contribute to an increasing burden of global diseases in the coming decades.
However, a pressing issue remains: while patients can promptly measure their metabolic health, they often lack access to qualified professionals who can help interpret these results. Bush and Smith note that most medical schools in the U.S. do not prioritize clinical nutrition training, with fewer than 15% of healthcare providers feeling confident enough to discuss nutrition critically with patients. Meanwhile, Certified Nutrition Specialists (CNS), who are trained specifically to interpret such metabolic data, are underutilized in healthcare settings. As stated by Bush and Smith, "When patients can measure their own metabolic state in real time but can't access a qualified professional to help interpret it, the system has failed at a basic level. Fixing that failure is a policy choice, and the mechanisms to make it are already available."
To bridge this gap, the Outlook makes three crucial recommendations: 1. Clinical societies should publish clear guidelines on using tools like the GKI. 2. States need to update licensing laws for nutrition professionals, enabling them to practice medical nutrition therapy based on demonstrated competencies rather than outdated regulations. 3. Insurance companies should reimburse biomarker-informed nutritional care rather than treating it as an optional service.
Bush and Smith emphasize that reimbursement reform could have the most immediate impact. With healthcare payers having a financial incentive to mitigate chronic disease costs, they argue that covering biomarker testing in accordance with established guidelines can be an immediate change that insurers could implement.
The Policy Outlook represents ANA's most notable engagement with policy discourse beyond professional education. This marks a pivotal moment for the organization as it advocates for a credentialed workforce in personalized nutrition parallel to emerging clinical science on a global scale.
To access the Policy Outlook, visit policylabs.frontiersin.org, where it sits alongside a lead article on GKI, a reader-friendly piece for younger audiences through Frontiers for Young Minds, and an expert viewpoint by Dr. Evelyne Bischof of the Healthy Longevity Medicine Society. A deep-dive webinar will follow on September 16, 2026.
About the American Nutrition Association: The ANA is a nonprofit organization dedicated to embedding personalized nutrition within the healthcare framework. They oversee the Certified Nutrition Specialist® (CNS®) credential, an NCCA-accredited certification, and engage in nationwide advocacy, continuing education, and workforce development for nutrition professionals.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.